miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-27
DOI
10.3389/fimmu.2020.00890
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppressor miR-128-3p inhibits metastasis and epithelial–mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer
- (2018) Lili Zhao et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy
- (2018) Yoji Murata et al. CANCER SCIENCE
- microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Anti-tumor Immune Response and Poor Outcomes of Patients
- (2018) Luigi Mari et al. GASTROENTEROLOGY
- MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
- (2018) Wei Huang et al. Molecular Cancer
- CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT
- (2018) Muhammad Zaeem Noman et al. OncoImmunology
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
- (2017) Meng Michelle Xu et al. IMMUNITY
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression
- (2017) Weiqun Lu et al. Oncotarget
- The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1
- (2017) Michele Cioffi et al. Oncotarget
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
- (2016) Yiwei Li et al. International Journal of Biological Sciences
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)
- (2015) RAMADEVI SUBRAMANI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1
- (2015) X. Sun et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression
- (2015) Adam E Frampton et al. LANCET
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
- (2015) Seung Yeob Yang et al. Oncotarget
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152
- (2012) Ho-Hyung Woo et al. Molecular Cancer
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a MicroRNA that Activates Gene Expression by Repressing Nonsense-Mediated RNA Decay
- (2011) Ivone G. Bruno et al. MOLECULAR CELL
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
- (2009) Siddhartha Jaiswal et al. CELL
- The role of the ZEB family of transcription factors in development and disease
- (2008) C. Vandewalle et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started